Search | DIAL.pr - BOREAL

Accès à distance ? S'identifier sur le proxy UCLouvain

Displaying 3 results.

- Journal article
Dose-dense rituximab-CHOP compared with standard rituximab-CHOP in elderly patients with diffuse large B-cell lymphoma (the LNH03-6B study): A randomised phase 3 trial
Delarue, R. Tilly, H. Mounier, N. Petrella, T. Salles, G. Thieblemont, C. Bologna, S. Ghesquières, H. Hacini, M. Fruchart, C. Ysebaert, L. Fermé, C. Casasnovas, O. Van Hoof, A. Thyss, A. Delmer, A. Fitoussi, O. Molina, T.J. Haioun, C. Bosly, André[UCL] (2013) The Lancet Oncology — Vol. 14, no.6, p. 525-533 (2013)
- Journal article
Phase III study of ACVBP versus ACVBP plus rituximab for patients with localized low-risk diffuse large B-cell lymphoma (LNH03-1b)
Ketterer, N. Coiffier, B. Thieblemont, C. Fermé, C. Brière, J. Casasnovas, O. Bologna, S. Christian, B. Connerotte, Thierry[UCL] Réher, C. Bordessoule, D. Fruchart, C. Delarue, R. Bonnet, C. Morschhauser, F. Anglaret, B. Soussain, C. Fabiani, B. Tilly, H. Haioun, C. (2013) Annals of Oncology — Vol. 24, no. 4, p. 1032-1037 (2013)
- Journal article
Treatment of older patients with mantle-cell lymphoma.
Kluin-Nelemans, H.C. Hoster, E. Hermine, O. Walewski, J. Trneny, M. Geisler, C.H. Stilgenbauer, S. Thieblemont, C. Vehling-Kaiser, U. André, Marc (2012) New England Journal of Medicine — Vol. 367, no. 6, p. 520-531 (2012)